📊 DETAILS
Sector: Pharmaceuticals & Drugs
Mkt Cap: 21,545 cr
Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership
position in select Active Pharmaceutical Ingredients (APIs) including anti-retroviral, oncology drugs (incl High Potent APIs), Cardiovascular, and Gastro therapeutics. They also offer integrated CMO and CDMO services to Global Innovators from Clinical phase drug development to commercial manufacturing.
Laurus employs 6500+ people, including around 1050+ scientists at more than 11 facilities approved by global agencies USFDA, WHO-Geneva, Japan-PDMA, UK-MHRA, EMA, TGA etc.
TTM PE : 58.61 (High PE)
Sector PE : 47.13
Beta : 0.73
📚 INSIGHTS
Mid range performer
Stock with medium financial performance with average price momentum and valuation. These stocks may be affordable and are showing some investors interest.
7.73% away from 52 week high
Underperformer - Laurus Labs up by 4.26% v/s NIFTY 50 up by 8.74% in last 1 month
📈 FINANCIALS
Piotroski Score of 5/9 indicates Average Financials
Disclaimer: This analysis is for educational purposes only, and I'm not a SEBI registered analyst.
If you found this analysis helpful, I encourage you to like and share it. Your observations and comments are also welcomed below. Your support, likes, follows, and comments motivate me to consistently share valuable insights with you.
🔍 More Analysis & Trade Setups 🔍
For more technical analysis and trade setups, make sure to follow me on TradingView: www.tradingview.com/u/Munish_Jain/
Sector: Pharmaceuticals & Drugs
Mkt Cap: 21,545 cr
Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership
position in select Active Pharmaceutical Ingredients (APIs) including anti-retroviral, oncology drugs (incl High Potent APIs), Cardiovascular, and Gastro therapeutics. They also offer integrated CMO and CDMO services to Global Innovators from Clinical phase drug development to commercial manufacturing.
Laurus employs 6500+ people, including around 1050+ scientists at more than 11 facilities approved by global agencies USFDA, WHO-Geneva, Japan-PDMA, UK-MHRA, EMA, TGA etc.
TTM PE : 58.61 (High PE)
Sector PE : 47.13
Beta : 0.73
📚 INSIGHTS
Mid range performer
Stock with medium financial performance with average price momentum and valuation. These stocks may be affordable and are showing some investors interest.
7.73% away from 52 week high
Underperformer - Laurus Labs up by 4.26% v/s NIFTY 50 up by 8.74% in last 1 month
📈 FINANCIALS
Piotroski Score of 5/9 indicates Average Financials
Disclaimer: This analysis is for educational purposes only, and I'm not a SEBI registered analyst.
If you found this analysis helpful, I encourage you to like and share it. Your observations and comments are also welcomed below. Your support, likes, follows, and comments motivate me to consistently share valuable insights with you.
🔍 More Analysis & Trade Setups 🔍
For more technical analysis and trade setups, make sure to follow me on TradingView: www.tradingview.com/u/Munish_Jain/
Trade attivo
Trade attivo